Videos

Symposium:

Home monitoring, artificial intelligece diagnostics and extended duration anti-VEGF therapeutics
Interview:

AMD & DME Patient Demographics and the Anti-VEGF Treatment Burden

Interview:

Emerging Therapeutics & Sustained Release Devices

Interview:

Artificial Intelligence & Home Monitoring in AMD & DME Treatment

Podcasts

Podcasts

Part 1

AMD & DME patient demographics and
the anti-VEGF treatment burden:

In the first episode of the EURETINA podcast series on AMD & DME Innovations Drs. Anat Loewenstein and Carl Awh talk about the differences between nAMD and DME patient groups and patient compliance with treatment schedules. To hear the entire interview, make sure to listen to the remaining two podcasts in this series. Independent medical education support provided by Roche and Zeiss.

Podcasts

Part 2

Emerging therapeutics and sustained release devices

In the second episode of the EURETINA podcast series on AMD & DME Innovations Drs. Anat Loewenstein and Carl Awh discuss new therapeutic options and sustained release devices addressing the need for longer lasting durability of wet AMD treatments. To hear the entire interview, make sure to listen to the remaining two podcasts in this series. Independent medical education support provided by Roche and Zeiss.

Podcasts

Part 3

Artificial intelligence and home monitoring in AMD and DME

In the third episode of the EURETINA podcast series on AMD & DME Innovations Drs. Anat Loewenstein and Carl Awh review the use of AI and at-home patient monitoring in retina practices today. They discuss advantages, limitations, and future applications of these technologies. To hear the entire interview, make sure to listen to the remaining two podcasts in this series. Independent medical education support provided by Roche and Zeiss.

eLearning

Current and Future Applications
of Longer Lasting Anti-VEGF Therapeutics

This short course by Prof Ramin Tadayoni examines the current and future applications of longer lasting Anti-VEGF therapeutics.

Artificial Intelligence (AI) in
nAMD & DME Treatment Decision-making

This short course by Prof Anat Loewenstein explores the development and applications of AI and OCT at-home monitoring in nAMD and DME treatment.

Insights and Pearls on
Implantable Sustained Release Technologies

Get a better insight and practical pearls on the use of implantable sustained release technologies for anti-VEGF delivery in AMD patients in this short course by Dr Carl Awh.

Archive

Independent medical education support provided by Roche | ZEISS